‘Science is everything’
Olaposi Idowu Omotuyi has traveled the world for his education, and he believes in bringing the knowledge he’s gained back to his home country. His focus, for now, is on metabolic and infectious diseases with a special interest in developing plant-based antivirals.
Benin, Nigeria, and then studied pharmaceutical science in Japan before
returning to Nigeria to teach and do research.
Born in Ekiti State, Nigeria, Omotuyi was interested in science from a young age. One of his neighbors was a professor whose children were in training for medical lab science. They discussed their work with Omotuyi, kick-starting his fascination with how the world worked.
“In Africa, everything was voodoo until you understood what exactly what was going on,” he said. “That somebody could sit down and explain to me how the cells work, how tissues work, how organs interconnect into systems — that was fascinating.”
After completing his doctorate in biochemistry from the University of Benin, Nigeria, Omotuyi applied for a Japanese government Ministry of Education, Culture, Sports, Science and Technology scholarship in 2009. Through the program, scientists from all over the world conduct research in Japan. After several stages of interviews, Omotuyi was one of five applicants chosen for a position at Nagasaki University to work toward his second doctoral degree in pharmaceutical science.
In Japan, in a first-class laboratory and heavy scientific environment, he saw a sharp contrast between an industrialized country and Nigeria. He said he believes some African scientists might be tempted to stay in a country like Japan to do research, while others want to raise the level of science in Africa by returning to their home country. In the end, he chose to bring his skills back to Nigeria.
Fund, a tour of the Institute for Drug Research and Development at Afe Babalola
University.
The science was not the only thing that drew Omotuyi back. For him, being a tutor to undergraduate students first at Adekunle Ajasin University in Ondo State and now as a professor at the College of Pharmacy at Afe Babalola University, Ado-Ekiti, is “an absolute joy.”
“Not only being able to teach this experience, this knowledge to young people, but to be able to help them grow scientifically,” Omotuyi said. “I am really impressed at how they receive it.”
Few Nigerian scientists are able to translate their research into a product or policy that then is disseminated to a wide population in their country. Omotuyi said he has been fortunate in his networking and in the subject of his research to receive funding from the Afe Babalola University fund for translational research as well as garnering attention from other institutions for partnerships and funding. His lab now is studying both metabolic diseases and infectious diseases such as Ebola and COVID-19, which attracts government attention and resources.
An herbal drug called virudine developed in Omotuyi’s lab for the treatment of COVID-19 is undergoing independent investigation at the Nigerian Institute for Medical Research, and another repurposed drug for Lassa virus disease developed in partnership with the National Biotechnology Development Agency in Nigeria is being tested for proof-of-concept clinical trials by the NIMR.
Omotuyi teaches his students the importance of patriotism in their work. In countries like the United States, he sees that scientists apply research to their local environments and local problems, and these local solutions are accepted for international application. But African scientists end up doing research that benefits other countries instead of their own.
“African scientists who are exceptional at what they do are easily poachable,” Omotuyi said.
“The first point of science for me is that (my students) should solve local problems — and in solving them they should be innovative.”
Omotuyi said his favorite part of his work is getting to the biochemical details of how novel structures interact with macromolecules like proteins and nucleic acids, both during test tube experiments and in animal research models. But overall, the entire subject of biochemistry is what interests him.
“Science is something for me, like bread and drink, wake, sleep — everything,” he said. “Science, and nothing else.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreFeatured jobs
from the
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
ASBMB committees welcome new members
Committee members serve terms of two to five years, and a number of new members have joined. We also thank those whose terms have ended.
Curiosity turned a dietitian into a lipid scientist
Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
Awards for Alrubaye and Dutta; Strochlic named ass't dean
PSA presents Early Achievement Award for Teaching to Adnan Alrubaye. ASIP honors Anindya Dutta with the Rous–Whipple Award. Drexel names Todd Strochlic assistant dean of curricular integration.
In memoriam: Arnis Kuksis
He was a professor emeritus at the University of Toronto who studied the complex mechanisms dictating lipid metabolism and an ASBMB member for more than 40 years.